Colgate Palmolive (CL) Capital Expenditures (2009 - 2026)

Colgate Palmolive has reported Capital Expenditures for 18 years, with the latest figure at $128.0 million in Q2 2026.

• On a quarterly basis, Capital Expenditures rose 18.52% year-over-year to $128.0 million in Q2 2026; TTM through Jun 2026 was $598.0 million, a 8.73% increase from a year earlier, with the FY2025 full-year figure at $564.0 million, up 0.53% from the prior year.
• Capital Expenditures was $128.0 million for Q2 2026 at Colgate Palmolive, down from $138.0 million in the prior quarter.
• The five-year high for Capital Expenditures was $221.0 million in Q4 2022, with the low at $108.0 million in Q2 2025.
• Average Capital Expenditures over 5 years is $155.1 million, with a median of $158.0 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Capital Expenditures surged 36.92% in 2022, then slumped 36.41% in 2024.
• Over 5 years, Capital Expenditures stood at $221.0 million in 2022, then declined by 10.86% to $197.0 million in 2023, then slipped by 6.6% to $184.0 million in 2024, then declined by 3.8% to $177.0 million in 2025, then slipped by 27.68% to $128.0 million in 2026.
• The last three Capital Expenditures figures came in at $128.0 million (Q2 2026), $138.0 million (Q1 2026), and $177.0 million (Q4 2025), per Business Quant data.